Skip to main content
Seres Therapeutics, Inc. logo

Seres Therapeutics, Inc. — Investor Relations & Filings

Ticker · MCRB ISIN · US81750R2013 LEI · 549300GMXBE5NUWISF13 US Manufacturing
Open in API
Filings indexed 668 across all filing types
Latest filing 2022-05-09 Regulatory Filings
Country US United States of America
Listing US MCRB

About Seres Therapeutics, Inc.

https://www.serestherapeutics.com/

Seres Therapeutics, Inc. is a commercial-stage biotechnology company developing microbiome-based therapeutics. The company's platform creates a novel class of biological drugs, known as live biotherapeutics, which consist of rationally selected consortia of live bacteria. These therapies are designed to modulate the functional properties of the gastrointestinal microbiome to treat and prevent diseases. Seres' development programs target medically vulnerable patient populations, with a focus on preventing bacterial bloodstream and antimicrobial-resistant (AMR) infections, as well as treating gastrointestinal-related immune diseases.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2022
Regulatory Filings
2022-05-09 English
POS AM
Capital/Financing Update Classification · 95% confidence The document is titled 'POST-EFFECTIVE AMENDMENT NO. 3 TO Form S-3 REGISTRATION STATEMENT' filed with the SEC. It references the Securities Act of 1933 and discusses registration of securities, underwriting agreements, indemnification of directors and officers, and exhibits related to securities offerings. The document is a post-effective amendment to a registration statement, which is a filing related to securities issuance and capital raising activities. It is not a financial report, earnings release, or management discussion. The presence of Form S-3 and the nature of the content clearly indicate this is a capital/financing update filing. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains detailed amendment information, not just an announcement, supporting a high confidence score.
2022-05-04 English
10-Q
Interim / Quarterly Report Q1 2022
2022-05-04 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated May 4, 2022, reporting the company's financial results for the quarter ended March 31, 2022. It includes a press release as an exhibit announcing quarterly financial results and operational updates. The text explicitly states it is a Current Report on Form 8-K and the financial results are announced via a press release. The document is relatively short (3717 characters) and does not contain detailed financial statements or comprehensive analysis, only an announcement of quarterly results. This matches the definition of an Earnings Release (ER), which is the initial announcement of quarterly/periodical financial results with key highlights only. Therefore, the correct classification is ER with high confidence.
2022-05-04 English
DEFA14A
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Schedule 14A filing, which is a Proxy Statement filed pursuant to Section 14(a) of the Securities Exchange Act of 1934. It includes information about the upcoming Annual Meeting, voting instructions, and proposals such as election of directors, appointment of auditors, and advisory approval of executive compensation. The document is titled 'Proxy Statement' and is clearly related to soliciting shareholder votes for the Annual General Meeting. It does not contain financial statements or detailed financial performance data, nor is it an announcement of a report publication. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI). The document length is 3281 characters, which is typical for proxy materials. Confidence is high due to explicit references to proxy materials and voting items.
2022-04-29 English
DEF 14A
Proxy Solicitation & Information Statement
2022-04-29 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.